This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit November 26, 2014


 

Advertisement

Scientists unveil powerful method to speed cancer drug discovery
Lab Manager
VideoBriefFor decades, researchers have struggled to translate basic scientific discoveries about cancer into therapeutics that effectively — and with minimal side effects — shrink a tumor. One avenue that may hold great potential is the development of drugs that interfere with interactions between proteins, which are often disrupted during the formation and spread of cancer. Deciphering these interactions, however, has proven difficult and time consuming, leading to doubts about the practicality of this approach as a route to new therapies.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Advertisement


Pursuing Excellence through NAPBC Accreditation: Register now
NAPBC
Whether you are preparing for a re-accreditation survey, first survey, or looking for information on the National Accreditation Program for Breast Centers (NAPBC), this education program gives you the information you need. Avoid the fee increase; register today.

Pursuing Excellence through NAPBC Accreditation is the only education program developed and taught by NAPBC staff, board members, and surveyors. This program prepares your breast center for survey and helps staff not familiar with the NAPBC standards understand their role in the accreditation process.


Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
SPONSORED CONTENT


Hookah smoke increases benzene exposure, risk for leukemia
Medical News Today
Tobacco use is the leading preventable cause of mortality worldwide and is responsible for the deaths of 6 million people annually. Hookah smoking — a form of tobacco use that employs a partially filled water jar — has come under scrutiny in a new study, which suggests hookah smokers and nonsmokers exposed to the smoke have increased uptake of benzene, a substance linked to increased risk of leukemia.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
PRODUCT SHOWCASE
  25th Anniversary Breast Center Conference
Join our 25th Annual Interdisciplinary Breast Center Conference! An empowering four-day event offering nine postconferences, workshops, and advanced hands-on training you don't want to miss. This event is for all medical professionals who specialize in breast care from screening to diagnosis, adjuvant therapy to survivorship.
  • 2015 Conference Syllabus
  • Conference Registration
  • http://www.breastcare.org
  •  


    Breast removal rates increasing for early cancers in U.S.
    Reuters Health
    More women in the U.S. are choosing to have their breasts removed for early cancers instead of breast-conserving procedures that deliver equal results, according to a new study. The researchers don't suggest that either choice is wrong or right. They do point to a recent 34 percent rise in the likelihood a woman will opt for total breast removal as a trend that needs further study to make sure women are being well informed about their risks.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Registration Now Open for Accreditation 101: Learning the Basics of CoC Accreditation and Standards
    The Commission on Cancer (CoC), a Quality Program of the American College of Surgeons, encourages you to attend Accreditation 101: Learning the Basics of CoC Accreditation and Standards in Chicago on February 27, 2015. This program provides practical information on how to achieve compliance, and discusses your role as a member of a patient-centered, multidisciplinary cancer car team. This is the only education program that is developed and taught by CoC surveyors and staff. Learn how to turn theory into reality and see how the CoC standards can be used a guide for the development of a high-quality program that treats patients with cancer.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Researchers identify new ways to drain cancer's 'fuel tank'
    Medical Xpress
    Scientists at the University of Manchester have discovered a potential weakness in cancer's ability to return or become resistant to treatment; by targeting the "fuel" part of stem cells that allows tumors to grow. Cancer stem cells are particularly difficult to eradicate and are at the heart of why it is so hard to more effectively treat cancer patients, as the posttreatment survival of cancer stem cells drives tumor recurrence, the systemic spread of cancer, and ultimately, treatment failure.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Fixing a broken system to improve pediatric cancer research
    FinancialBuzz
    In the past, we have heard representatives on Capitol Hill talk about fixing a broken health care system and fixing the banking system. A serious topic to be addressed, though, is whether or not a drug development process for pediatric cancer exists. This question has been raised not by a politician, but by a mother whose son passed away almost six years ago from medulloblastoma, a malignant brain cancer that affects less than two people per million per year. However, the disease is much more common in children than adults — about 10 times more prevalent.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Tumor screening: Making resistance futile?
    PHG Foundation
    Cancer treatments are at the front line of personalized approaches to health care, with genetic testing and analysis of tumors allowing the use of the most effective drugs to attack them, including new biologically targeted treatments that can be highly effective without the side effects (toxicity) of wider-acting drugs. However, as with infectious pathogens, tumors can become resistant to even the most powerful prescribed treatment, often within a few months, rendering the patient's original course of therapy futile.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Vitamin B3 actually cures a liver cancer in mice
    Cherry Creek News
    The power of B vitamins continues to impress as research into these essential micronutrients moves forward. The first mouse model that faithfully reproduces the steps of human HCC development has been developed by researchers. The results of the study indicate that diets rich in nicotinamide riboside, a derivative of vitamin B3, protect these mice from developing HCC in its most initial stage, when genotoxic stress is damaging cellular DNA. They also show a curative effect of the diet in those mice that had previously developed the disease.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    'Huge breakthrough' in understanding how the immune system recognizes cancer
    Cancer Research UK
    U.S. researchers have revealed the identity of molecules on the surface of cancer cells that allow the body's immune system to identify and destroy them. The research could lead to a new generation of immunotherapies that are far more effective than those currently in use and that could target a range of cancers.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    TRENDING ARTICLES
    Missed last week's issue? See which articles your colleagues read most.

        Cost of treating skin cancer is skyrocketing (Consumer Affairs)
    Triclosan, a common antimicrobial in personal hygiene products, causes liver fibrosis and cancer in mice (Medical Xpress)
    Cannabis can help cure brain cancer, research finds (UPI)
    Genetic-based NanoFlare technology can detect live cancer cells in the bloodstream (AZoNano)
    Two experts discuss mammography issues on The Recovery Room Show (NAPBC)

    Don't be left behind. Click here to see what else you missed.
     
    Advertisement



    The CoC Brief

    Colby Horton, Vice President of Publishing, 469.420.2601
    Download media kit

    Ashley Whipple, Senior Content Editor, 469.420.2642
    Contribute news

    Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.


    Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

    This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

    Recent issues

    Nov. 19, 2014
    Nov. 12, 2014
    Nov. 5, 2014
    Oct. 29, 2014






    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063